Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

LIPO-C Real vs Fake: Visual and Chemical Comparison

Reconstitution clarity Clear amber solution within 90 seconds, zero particulate matter Cloudy, incomplete dissolution, visible sediment or off-white particles Cloudiness indicates impure precursors or incorrect amino acid ratios. Immediate rejection criterion

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Reconstitution clarity
  • Clear amber solution within 90 seconds, zero particulate matter
  • Cloudy, incomplete dissolution, visible sediment or off-white particles
  • Cloudiness indicates impure precursors or incorrect amino acid ratios. Immediate rejection criterion
  • pH stability (15 min post-mix)
  • 5.5–6.5 on standard pH strips
  • <5.0 or >7.0, indicating poor buffering or degradation byproducts
  • pH drift is the clearest chemical fingerprint of illicit manufacturing. Authentic formulations maintain narrow range
  • Third-party COA
  • Batch-specific HPLC from ISO 17025-accredited lab, ≥98% purity
  • No COA, generic document, or visibly altered report
  • Lack of verifiable third-party testing is the single strongest indicator of grey-market sourcing
  • Storage temperature at delivery
  • Arrives cold (2–8°C) with gel packs and temperature indicators
  • Room temperature, no cold chain packaging
  • Temperature excursion above 8°C for >48 hours denatures amino acids irreversibly. Renders product ineffective
  • Supplier transparency
  • Provides synthesis facility name, FDA registration number, batch traceability
  • Vague claims ('FDA-approved facility'), no specific facility details
  • Legitimate suppliers disclose manufacturing origin without hesitation. Vagueness signals grey-market operations
  • Solution colour intensity
  • Deep amber hue from cyanocobalamin at therapeutic concentration
  • Pale yellow or colourless, indicating B12 deficiency or substitution
  • Colour intensity correlates directly with B12 content. Pale solutions fail potency standards